Results 1 to 10 of about 271,468 (359)

Epigenetic regulation of monoallelic rearrangement (allelic exclusion) of antigen receptor genes [PDF]

Frontiers in Immunology, 2014
While most genes in the mammalian genome are transcribed from both parental chromosomes in cells where they are expressed, approximately 10% of genes are expressed monoallelically, so that any given cell will express either the paternal or maternal ...
Rena eLevin-Klein, Yehudit eBergman
doaj   +2 more sources

Prevalence of Gene Rearrangement by Multiplex PCR in De Novo Acute Myeloid Leukemia in Adult Iraqi Patients [PDF]

Journal of Blood Medicine, 2023
Ali AlJabban, Jaffar Alalsaidissa Department of Pathology, College of Medicine, University of Baghdad, Baghdad, IraqCorrespondence: Ali AlJabban, Department of Pathology, College of medicine, University of Baghdad, Baghdad, Iraq, Tel +9647706056226 ...
AlJabban A, Alalsaidissa J
doaj   +2 more sources

Characterization of Acute Myeloid Leukemia With RUNX1/RUNX1T1 Gene Rearrangement: Clinical, Hematological, and Morphological Features. [PDF]

Cureus
Maqbool S, Maqbool I, Yousaf M, Farooqi B, Sikandar MZ, Zainab R, Bakht K, Shahid M.   +7 more
europepmc   +2 more sources

Comparative Mitogenomic Analyses of Hydropsychidae Revealing the Novel Rearrangement of Protein-Coding Gene and tRNA (Trichoptera: Annulipalpia)

Insects, 2022
Gene rearrangement of the mitochondrial genome of insects, especially the rearrangement of protein-coding genes, has long been a hot topic for entomologists.
Xinyu Ge, Haoming Zang, Xiaoyun Ye, Lang Peng, Beixin Wang, Gang Lian, Changhai Sun   +6 more
doaj   +1 more source

Rearranging Detection of Gene Rearrangements [PDF]

Journal of Thoracic Oncology, 2015
®ecent years have witnessed a dramatic expansion in our knowledge of the genetic diversity of non–small-cell lung cancer (NSCLC), and in particular adenocarcinoma. This appreciation of the genetic landscape of the disease has resulted in the development of targeted therapies that are directed to ward activated oncogenes.
Davies, Kurtis D., Doebele, Robert C., Aisner, Dara L.   +2 more
openaire   +2 more sources

Positive Correlation of the Gene Rearrangements and Evolutionary Rates in the Mitochondrial Genomes of Thrips (Insecta: Thysanoptera)

Insects, 2022
Extensive gene rearrangement is characteristic in the mitogenomes of thrips (Thysanoptera), but the historical process giving rise to the contemporary gene rearrangement pattern remains unclear.
Qiaoqiao Liu, Jia He, Fan Song, Li Tian, Wanzhi Cai, Hu Li   +5 more
doaj   +1 more source

Successful treatment of a pure red-cell aplasia patient with γδT cells and clonal TCR gene rearrangement: A case report

Frontiers in Immunology, 2023
Pure red-cell aplasia (PRCA) is a syndrome associated with reduced erythroid precursors. This report presents the case of an elderly PRCA patient with significantly proliferated γδT cells and clonal T-cell receptor (TCR) gene rearrangement.
Xian Li, Xinyi Zhu, Xiaohong Zhang, Weiqin Wang   +3 more
doaj   +1 more source

Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma

Frontiers in Immunology, 2021
Multiple gene-driven programmed cell death 1 ligand 1 (PD-L1)-expressing non-small-cell lung cancer (NSCLC) is very rare. Previous studies have shown that patients with NSCLC with anaplastic lymphoma kinase (ALK) gene rearrangement rarely benefit from PD-
Wen Dong, Pengfei Lei, Xin Liu, Qin Li, Xiangyang Cheng   +4 more
doaj   +1 more source

Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme. [PDF]

PLoS ONE, 2015
Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor, and the prognosis remains poor. Rearrangement of ROS1 gene, which was shown to have an oncogenic potential, was previously discovered in GBM cell lines.
Sun Min Lim, Junjeong Choi, Jong Hee Chang, Jinyoung Sohn, Kristine Jacobson, Frank Policht, John Schulz, Byoung Chul Cho, Se Hoon Kim   +8 more
doaj   +1 more source

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)

Frontiers in Oncology, 2020
Background: In patients with anaplastic lymphoma kinase (ALK) rearrangement-positive advanced non–small-cell lung cancer (NSCLC), ALK inhibitors are now the standard treatment, but their clinical efficacy varies widely for each patient.
Meichen Li, Xue Hou, Chengzhi Zhou, Weineng Feng, Guanming Jiang, Hao Long, Shuang Yang, Jing Chen, Na Wang, Kaicheng Wang, Likun Chen   +10 more
doaj   +1 more source